期刊文献+

人骨保护素编码区基因的克隆及其真核表达载体的构建 被引量:1

Cloning of human osteoprotegerin and construction of mammalian expression vector pcDNA3.1-OPG-IRES-EGFP
下载PDF
导出
摘要 目的克隆人骨保护素(OPG)编码区基因并构建其真核表达载体。方法以人骨肉瘤细胞系MG63总RNA为模板,采用RT-PCR方法获取OPG编码区基因核苷酸序列,应用定向克隆技术,构建真核表达载体pcDNA3.1-OPG-IRES-EGFP。结果获取的OPG编码区全长核苷酸序列与文献报道的完全一致,经PCR和多酶切鉴定证实构建的表达载体正确。结论获得了人骨保护素(OPG)编码区基因,并成功构建了其真核表达载体。 Objective To clone the encoding gene of human osteoprotegerin(hOPG)and construct the eukaryotic expression vector pcDNA3.1-OPG-IRES-EGFP.Methods Using the isolated total RNA from osteosacoma cell line MG63 as a template,the cDNA encoding hOPG was amplified by reverse transcription-polymerase chain reaction method.Further,the PCR product was cloned into pGEM-T Easy and sequenced.Finally,Recombinant vector pcDNA3.1-OPG-IRES-EGFP was constructed by directionally cloning the target gene fragments into eukaryotic expression vector pcDNA3.1(+).Results The OPG cDNA was identical with related literatures,and the recombinant vector pcDNA3.1-OPG-IRES-EGFP was verified by extensive restriction digests and PCR.Conclusion The OPG cDNA is obtained and the recombinant plasmid is constructed successfully.
出处 《山西医科大学学报》 CAS 2007年第8期673-676,共4页 Journal of Shanxi Medical University
关键词 骨保护素 基因克隆 载体构建 osteoprotegerin gene cloning vector construction
  • 相关文献

参考文献9

  • 1Simnonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:a novel secreted protein involved in the regulation of bone density[J].Cell,1997,89:309-319.
  • 2L0000i CY,Price C,Delisser K,et al.Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis[J].J Bone Miner Res,2005,20:117-124.
  • 3Morony S,Warmington K,Adamu S,et al.The RANKL inhibitor osteoprotegerin (OPG) causes greater suppression of bone resorption and hypercalcemia compared to bisphosphonates in two models of humoral hypercalcemia of malignancy[J].Endocrinology,2005,146:3235-3243.
  • 4Kostenuik PJ,Bolon B,Morony S,et al.Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice[J].Bone,2004,34(4):656-664.
  • 5Haynes DR,Crotti TN,Potter AE,et al.The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis[J].J Bone Joint Surg,2001,83B:902-911.
  • 6Hofbauer LC,Khosla S,Dunstan CR,et al.The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption[J].J Bone Miner Res,2000,15:2.
  • 7Hayman B,Hirst R.Development of a semi-nested PCR for the improved detection of mycoplasma bovis from bovine milk and mucosal samples[J].Vet Microbiol,2003,91(2-3):91.
  • 8Hennecke M,Kwissa M,Metzger K,et al.Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs[J].Nucleic Acids Res,2001,29(16):3327-3334.
  • 9Wahlfors J,Loimas S,Pasanen T,et al.Green fluorescent p rotein (GFP) fusion constructs in gene therapy research[J].Histochem Cell Biol,2001,115(1):59-65.

同被引文献7

  • 1陈丽萍,杨富生,吴礼安.骨保护素的有关研究[J].牙体牙髓牙周病学杂志,2007,17(6):361-363. 被引量:7
  • 2Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density[J]. Cell, 1997, 89(2): 309-319.
  • 3Thomas RJ, Guise TA, Yin JJ, et al. Breast cancer cells interact with osteoblasts to support osteoclast formation [J ]. Endocrinology, 1999, 140(10): 4451-4458.
  • 4Kozlow W, Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy [J]. J Mammary Gland Biol Neoplasia, 2005, 10(2): 169-180.
  • 5Guise TA, Yin J J, Thomas R J, et al. Parathyroid hormonerelated protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo[J].Bone, 2002, 30(5): 670-676.
  • 6Holen I, Cross SS, Neville-Webbe HL, et al. Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo--a role in turnout cell survival [J]. Breast Cancer Res Treat, 2005, 92(3): 207-215.
  • 7Corey E, Brown LG, Kiefer JA, et al. Osteoprotegerin in prostate cancer bone metastasis[J]. Cancer Res, 2005, 65 (5): 1710-1718.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部